Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbaud

Showing results (461-470 of 532) with videos related to

Pageof 54
Sort By:
The British Journal of Dermatology|June 22, 2018
Omalizumab in patients with chronic spontaneous urticaria nonresponsive to H1-antihistamine treatment: results of the phase IV open-label SUNRISE studyF Bérard, M C Ferrier Le Bouedec, L Bouillet, et al.
Journal of the American Academy of Dermatology|May 23, 2020
Belimumab for refractory manifestations of cutaneous lupus: A multicenter, retrospective observational study of 16 patientsRomain Salle, François Chasset, Diane Kottler, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 7, 2013
Comparison of cytokine gene polymorphism in drug-induced maculopapular eruption, urticaria and drug reaction with eosinophilia and systemic symptoms (DRESS)A Barbaud, J Waton, B Herbeth, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 24, 2021
DRESS and AGEP Reactions to Iodinated Contrast Media: A French Case SeriesAngèle Soria, Emmanuelle Amsler, Claire Bernier, et al.
Frontiers in Pediatrics|July 25, 2022
Linear Immunoglobulin a Bullous Dermatosis in ChildrenFrancesca Mori, Francesca Saretta, Lucia Liotti, et al.
Journal of the American Academy of Dermatology|August 1, 2021
Hydroxychloroquine dose tapering or discontinuation in cutaneous lupus erythematosus after remission: A retrospective multicenter cohort study of 56 patientsGabrielle Sonigo, Marie Jachiet, Didier Bessis, et al.
Allergy|December 29, 2023
EAACI/ENDA position paper on drug provocation testingAnnick Barbaud, Lene Heise Garvey, Maria Torres, et al.
Allergy|July 30, 2013
Allergy to betalactams and nucleotide-binding oligomerization domain (NOD) gene polymorphismsA C Bursztejn, A Romano, R M Guéant-Rodriguez, et al.
Journal of the American Academy of Dermatology|January 24, 2025
Interferon-α biological activity is associated with disease activity and risk of flare in cutaneous lupus erythematosus: A monocentric study of 184 patientsQuitterie Murat de Montai, Clémence Masseran, Laura Perray, et al.
Allergy|November 28, 2023
Hypersensitivity reactions to proton pump inhibitors. An EAACI position paperSevim Bavbek, Seçil Kepil Özdemir, Patrizia Bonadonna, et al.
Pageof 54

Showing results (461-470 of 532) with videos related to

Sort By:
Pageof 54
The British Journal of Dermatology|June 22, 2018
Omalizumab in patients with chronic spontaneous urticaria nonresponsive to H1-antihistamine treatment: results of the phase IV open-label SUNRISE studyF Bérard, M C Ferrier Le Bouedec, L Bouillet, et al.
Journal of the American Academy of Dermatology|May 23, 2020
Belimumab for refractory manifestations of cutaneous lupus: A multicenter, retrospective observational study of 16 patientsRomain Salle, François Chasset, Diane Kottler, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 7, 2013
Comparison of cytokine gene polymorphism in drug-induced maculopapular eruption, urticaria and drug reaction with eosinophilia and systemic symptoms (DRESS)A Barbaud, J Waton, B Herbeth, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 24, 2021
DRESS and AGEP Reactions to Iodinated Contrast Media: A French Case SeriesAngèle Soria, Emmanuelle Amsler, Claire Bernier, et al.
Frontiers in Pediatrics|July 25, 2022
Linear Immunoglobulin a Bullous Dermatosis in ChildrenFrancesca Mori, Francesca Saretta, Lucia Liotti, et al.
Journal of the American Academy of Dermatology|August 1, 2021
Hydroxychloroquine dose tapering or discontinuation in cutaneous lupus erythematosus after remission: A retrospective multicenter cohort study of 56 patientsGabrielle Sonigo, Marie Jachiet, Didier Bessis, et al.
Allergy|December 29, 2023
EAACI/ENDA position paper on drug provocation testingAnnick Barbaud, Lene Heise Garvey, Maria Torres, et al.
Allergy|July 30, 2013
Allergy to betalactams and nucleotide-binding oligomerization domain (NOD) gene polymorphismsA C Bursztejn, A Romano, R M Guéant-Rodriguez, et al.
Journal of the American Academy of Dermatology|January 24, 2025
Interferon-α biological activity is associated with disease activity and risk of flare in cutaneous lupus erythematosus: A monocentric study of 184 patientsQuitterie Murat de Montai, Clémence Masseran, Laura Perray, et al.
Allergy|November 28, 2023
Hypersensitivity reactions to proton pump inhibitors. An EAACI position paperSevim Bavbek, Seçil Kepil Özdemir, Patrizia Bonadonna, et al.
Pageof 54